Cipla has achieved its highest-ever yearly revenue of INR 28,163 Cr for the fiscal year FY26, reflecting a resilient performance despite multiple headwinds. The company reported an EBITDA of INR 5,925 Cr with a 21.0% margin and a PAT of INR 3,879 Cr. These results underscore the company’s strong execution across its diverse global portfolio, including its flagship One India business and robust growth in international markets.
FY26 Financial Performance Highlights
Cipla delivered a strong financial performance in FY26, with total revenue from operations reaching INR 28,163 Cr. For the fourth quarter (Q4FY26), revenue stood at INR 6,541 Cr, with an EBITDA of INR 997 Cr (15.2% margin) and a PAT of INR 555 Cr. The company remains in a strong financial position, maintaining a net cash position of over $1 billion, which provides the necessary resources to fuel future growth investments.
Strategic Business Segment Growth
The One India business continues to be a primary growth engine, contributing INR 12,680 Cr to the annual revenue. This segment achieved double-digit growth across its three core sub-segments: Branded Prescription, Trade Generics, and Consumer Health. Notably, Cipla maintained its #2 rank in the overall chronic therapy segment, with key brands like Foracort surpassing the INR 1,000 Cr milestone in the Indian Pharmaceutical Market.
Global Operations and Market Expansion
In North America, the company continues to advance through a strategic asset pipeline, recently receiving regulatory approval for the first AB-rated gVentolin with CGT designation. The One Africa segment also saw significant progress, growing at 1.4x the market growth rate, with total revenue for the year reaching $483 Mn. These gains were supported by 18 new product launches throughout the fiscal year.
Commitment to Innovation and Sustainability
R&D remains a top priority, with an investment of INR 1,974 Cr (7.0% of revenue) in FY26 to support future product pipelines. Beyond financial success, Cipla has made significant strides in sustainability, achieving an 83% reduction in absolute scope 1 and scope 2 emissions against the FY20 baseline and reaching a status of 2.6 times water positive, reaffirming its dedication to long-term ESG goals.
Source: BSE
